İstanbul University, Cerrahpaşa School of Medicine, Department of Pneumophysiology, Division of Internal Medicine, İstanbul, Turkey.
İstanbul Training and Research Hospital, Department of Hematology, İstanbul, Turkey.
Turk J Haematol. 2012 Sep;29(3):217-22. doi: 10.5152/tjh.2011.77. Epub 2012 Sep 15.
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Pulmonary are among the most common causes of mortality in AML. This single-center retrospective study aimed to evaluate the relationship between radiological findings of pulmonary at presentation and post chemotherapy on prognosis and clinical outcome in a group of AML patients.
The study included 278 AML patients. Clinical and radiological findings, laboratory findings, and microbiological culture results were evaluated. Pulmonary complications at presentation and post chemotherapy were compared.
Pulmonary complications were observed in 53 of the patients (19%). Mean age of the patients with and without pulmonary complications was 43.1 ± 15.2 years and 38.8 ± 16.3 years, respectively (P < 0.001). Pulmonary complications were not correlated with gender, AML subtype, or the serum lactate dehydrogenase (LDH) level. The most common cause of pulmonary complications was infection. Pulmonary complications were observed in 29% and 71% of the patients at presentation and post chemotherapy, respectively.
Pulmonary complications were observed more frequently at presentation in neutropenic AML patients of advanced age. The mortality rate was higher among the AML patients that had pulmonary complications at presentation.
急性髓系白血病(AML)是成人中最常见的急性白血病。肺部感染是 AML 患者死亡的最常见原因之一。本单中心回顾性研究旨在评估 AML 患者肺部表现的影像学特征与化疗后预后和临床结局之间的关系。
研究纳入 278 例 AML 患者。评估了临床和影像学表现、实验室检查和微生物培养结果。比较了患者在就诊时和化疗后出现的肺部并发症。
53 例(19%)患者出现肺部并发症。有肺部并发症和无肺部并发症患者的平均年龄分别为 43.1 ± 15.2 岁和 38.8 ± 16.3 岁(P < 0.001)。肺部并发症与性别、AML 亚型或血清乳酸脱氢酶(LDH)水平无关。肺部并发症最常见的原因是感染。在就诊时和化疗后,分别有 29%和 71%的患者出现肺部并发症。
肺部并发症在高龄中性粒细胞减少性 AML 患者就诊时更为常见。在就诊时即有肺部并发症的 AML 患者死亡率更高。